{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:04:19Z","timestamp":1784642659899,"version":"3.55.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Children\u2019s Tumor Foundation Drug Discovery Initiative"},{"name":"Luminesce Alliance"},{"name":"Research Training Program (RTP) Scholarships from the Australian Government"},{"name":"Research Training Program (RTP) Scholarships from the Australian Government"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Neurofibromatosis type 1 (NF1) is a complex genetic disorder that affects a range of tissues including muscle and bone. Recent preclinical and clinical studies have shown that <jats:italic>Nf1<\/jats:italic> deficiency in muscle causes metabolic changes resulting in intramyocellular lipid accumulation and muscle weakness. These can be subsequently rescued by dietary interventions aimed at modulating lipid availability and metabolism. It was speculated that the modified diet may rescue defects in cortical bone as NF1 deficiency has been reported to affect genes involved with lipid metabolism. Bone specimens were analyzed from wild type control mice as well as <jats:italic>Nf1<\/jats:italic><jats:sub><jats:italic>Prx1<\/jats:italic><\/jats:sub><jats:sup>-\/-<\/jats:sup> (limb-targeted <jats:italic>Nf1<\/jats:italic> knockout mice) fed standard chow versus a range of modified chows hypothesized to influence lipid metabolism. Mice were fed from 4 weeks to 12 weeks of age. MicroCT analysis was performed on the cortical bone to examine standard parameters (bone volume, tissue mineral density, cortical thickness) and specific porosity measures (closed pores corresponding to osteocyte lacunae, and larger open pores). <jats:italic>Nf1<\/jats:italic><jats:sub><jats:italic>Prx1<\/jats:italic><\/jats:sub><jats:sup>-\/-<\/jats:sup> bones were found to have inferior bone properties to wild type bones, with a 4-fold increase in the porosity attributed to open pores. These measures were rescued by dietary interventions including a L-carnitine + medium-chain fatty acid supplemented chow previously shown to improve muscle histology function. Histological staining visualized these changes in bone porosity. These data support the concept that lipid metabolism may have a mechanistic impact on bone porosity and quality in NF1.<\/jats:p>","DOI":"10.1371\/journal.pone.0304778","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T17:22:24Z","timestamp":1719249744000},"page":"e0304778","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1)"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-3671","authenticated-orcid":true,"given":"Alexandra K.","family":"O\u2019Donohue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Vasiljevski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig F.","family":"Munns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-6281","authenticated-orcid":true,"given":"Aaron","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"issue":"8","key":"pone.0304778.ref001","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"E Legius","year":"2021","journal-title":"Genet Med"},{"issue":"7","key":"pone.0304778.ref002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrc1653","article-title":"Neurofibromatosis type 1\u2014a model for nervous system tumour formation?","volume":"5","author":"JB Rubin","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"pone.0304778.ref003","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1359\/jbmr.060603","article-title":"Ras-MAPK signaling in osteogenic differentiation: friend or foe?","volume":"21","author":"A Schindeler","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"4","key":"pone.0304778.ref004","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.bpb.0000271310.87997.ae","article-title":"Decreased bone mineral density in neurofibromatosis type 1: results from a pediatric cohort","volume":"27","author":"S Dulai","year":"2007","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"pone.0304778.ref005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5435\/00124635-199907000-00002","article-title":"Neurofibromatosis in children: the role of the orthopaedist","volume":"7","author":"AH Crawford","year":"1999","journal-title":"J Am Acad Orthop Surg"},{"issue":"8","key":"pone.0304778.ref006","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/dmcn.12777","article-title":"Muscle weakness in children with neurofibromatosis type 1","volume":"57","author":"KM Cornett","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"pone.0304778.ref007","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/hmg\/ddm032","article-title":"Multiple roles for neurofibromin in skeletal development and growth","volume":"16","author":"M Kolanczyk","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"1","key":"pone.0304778.ref008","doi-asserted-by":"crossref","first-page":"e86115","DOI":"10.1371\/journal.pone.0086115","article-title":"Multiscale, Converging Defects of Macro-Porosity, Microstructure and Matrix Mineralization Impact Long Bone Fragility in NF1","volume":"9","author":"J K\u00fchnisch","year":"2014","journal-title":"PLoS ONE"},{"key":"pone.0304778.ref009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bone.2014.06.012","article-title":"Neurofibromin inactivation impairs osteocyte development in Nf1Prx1 and Nf1Col1 mouse models","volume":"66","author":"J K\u00fchnisch","year":"2014","journal-title":"Bone"},{"issue":"5","key":"pone.0304778.ref010","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/hmg\/ddt515","article-title":"NF1 is a critical regulator of muscle development and metabolism","volume":"23","author":"K Sullivan","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"14","key":"pone.0304778.ref011","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/hmg\/ddr149","article-title":"Neurofibromin (Nf1) is required for skeletal muscle development","volume":"20","author":"N Kossler","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"4","key":"pone.0304778.ref012","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/ddx423","article-title":"Dietary intervention rescues myopathy associated with neurofibromatosis type 1","volume":"27","author":"MA Summers","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"8","key":"pone.0304778.ref013","doi-asserted-by":"crossref","first-page":"e0237097","DOI":"10.1371\/journal.pone.0237097","article-title":"Evaluating modified diets and dietary supplement therapies for reducing muscle lipid accumulation and improving muscle function in neurofibromatosis type 1 (NF1)","volume":"15","author":"ER Vasiljevski","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"pone.0304778.ref014","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/ajmg.a.62392","article-title":"L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial","volume":"185","author":"ER Vasiljevski","year":"2021","journal-title":"Am J Med Genet A"},{"issue":"2","key":"pone.0304778.ref015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/gene.10092","article-title":"Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer","volume":"33","author":"M Logan","year":"2002","journal-title":"Genesis"},{"issue":"7","key":"pone.0304778.ref016","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Y Zhu","year":"2001","journal-title":"Genes Dev"},{"issue":"7","key":"pone.0304778.ref017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41413-019-0070-y","article-title":"Osteocyte dysfunction promotes osteoarthritis through MMP13-dependent suppression of subchondral bone homeostasis","volume":"5","author":"CM Mazur","year":"2019","journal-title":"Bone Res"},{"issue":"6620","key":"pone.0304778.ref018","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/386078a0","article-title":"Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein","volume":"386","author":"G Luo","year":"1997","journal-title":"Nature"},{"issue":"3","key":"pone.0304778.ref019","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00223-018-0420-6","article-title":"Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume","volume":"103","author":"A Morse","year":"2018","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"pone.0304778.ref020","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bone.2005.01.022","article-title":"Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning","volume":"36","author":"X Yu","year":"2005","journal-title":"Bone"},{"issue":"11","key":"pone.0304778.ref021","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1172\/JCI29092","article-title":"Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions","volume":"116","author":"FC Yang","year":"2006","journal-title":"J Clin Invest"},{"issue":"1","key":"pone.0304778.ref022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jbmr.2316","article-title":"Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -\/- mice","volume":"30","author":"J de la Croix Ndong","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"8","key":"pone.0304778.ref023","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/jbmr.3155","article-title":"Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype","volume":"32","author":"N Kamiya","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"1","key":"pone.0304778.ref024","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/504441","article-title":"Double inactivation of NF1 in tibial pseudarthrosis","volume":"79","author":"DA Stevenson","year":"2006","journal-title":"Am J Hum Genet"},{"key":"pone.0304778.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2018.08.001","article-title":"Lipid storage myopathies: Current treatments and future directions","volume":"72","author":"ER Vasiljevski","year":"2018","journal-title":"Prog Lipid Res"},{"issue":"8","key":"pone.0304778.ref026","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/jbmr.4633","article-title":"Identifying Bone Matrix Impairments in a Mouse Model of Neurofibromatosis Type 1 (NF1) by Clinically Translatable Techniques","volume":"37","author":"R Ahmed","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"9","key":"pone.0304778.ref027","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1302\/2046-3758.69.BJR-2016-0317.R2","article-title":"Microindentation\u2014a tool for measuring cortical bone stiffness? A systematic review","volume":"6","author":"M Arnold","year":"2017","journal-title":"Bone Joint Res"},{"issue":"4","key":"pone.0304778.ref028","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2214.2006.00717.x","article-title":"The self-concept of children and adolescents with neurofibromatosis type 1","volume":"33","author":"B Barton","year":"2007","journal-title":"Child Care Health Dev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T17:23:06Z","timestamp":1719249786000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304778"}},"subtitle":[],"editor":[{"given":"Efthimios M. C.","family":"Skoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0304778","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,24]]}}}